Surgery Doctors in Bellevue, NE Accepting Medicare

2 Surgery doctors found. Showing 1 - 2

Mr. Matthew Joshua Wheeler, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 Bellevue Medical Center Dr, Bellevue, NE 68123 Phone: 402-763-3410

Robert Michael Taylor, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 Bellevue Medical Center Dr, Bellevue, NE 68123 Phone: 402-763-3410

News Archive

Higher consumption of added sugars in processed foods associated with lower levels of HDL-C: Study

Consuming a higher amount of added sugars in processed or prepared foods is associated with lower levels of high-density lipoprotein cholesterol and higher levels of triglycerides, which are important risk factors for cardiovascular disease, according to a study in the April 21 issue of JAMA.

Novartis, Bristol-Myers Squibb collaborate to examine combination therapies for metastatic colorectal cancer

Novartis today announced it has entered into a clinical research collaboration in which Bristol-Myers Squibb will investigate the safety, tolerability, and efficacy of Mekinist (trametinib) in combination with Opdivo (nivolumab) and Opdivo + Yervoy (ipilimumab) regimen as a potential treatment option for metastatic colorectal cancer in patients with microsatellite stable tumors where the tumors are proficient in mismatch repair (MSS mCRC pMMR).

U.S., British HIV/AIDS researchers pessimistic about prospects of vaccine, survey finds

Leading HIV/AIDS researchers in Britain and the U.S. are pessimistic about the prospects of developing an HIV vaccine following the recent failure of a Merck vaccine candidate, according to a survey conducted by London's Independent, the Independent reports (Connor/Green, Independent, 4/24).

The land of the long white cloud will soon be smoke-free

From 10 December 2004, all enclosed public places in New Zealand will be smoke-free zones.

Seattle Genetics reaches milestone under collaboration agreement with MedImmune

Seattle Genetics, Inc. (NASDAQ:SGEN), announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration agreement with MedImmune, LLC, a wholly owned subsidiary of AstraZeneca. The milestone was triggered by MedImmune's initiation of a phase I clinical trial of MEDI-547, its anti-EphA2 ADC for solid tumors.

Read more Medical News

› Verified 5 days ago